RWP
EW icon

RWA Wealth Partners’s Edwards Lifesciences EW Stock Holding History

RWA Wealth Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Buy
3,357
+76
+2% +$6.37K ﹤0.01% 565
2026
Q1 		$263K Buy
3,281
+36
+1% +$2.97K ﹤0.01% 563
2025
Q4 		$277K Buy
3,245
+59
+2% +$4.84K ﹤0.01% 538
2025
Q3 		$248K Buy
3,186
+581
+22% +$45.4K ﹤0.01% 563
2025
Q2 		$204K Buy
+2,605
New +$194K ﹤0.01% 577
2025
Q1 		– Sell
-3,120
Closed -$231K – 555
2024
Q4 		$231K Hold
3,120
– – ﹤0.01% 523
2024
Q3 		$206K Sell
3,120
-2,543
-45% -$185K ﹤0.01% 541
2024
Q2 		$523K Buy
5,663
+110
+2% +$9.74K 0.01% 386
2024
Q1 		$531K Buy
5,553
+2,433
+78% +$204K 0.01% 390
2023
Q4 		$238K Buy
+3,120
New +$217K ﹤0.01% 482
2023
Q3 		– Sell
-2,425
Closed -$229K – 378
2023
Q2 		$229K Buy
+2,425
New +$211K 0.01% 301
2018
Q3 		– Sell
-69
Closed -$3K – 385
2018
Q2 		$3K Hold
69
– – ﹤0.01% 707
2018
Q1 		$3K Buy
+69
New +$3K ﹤0.01% 522

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

RWA Wealth Partners's EW Position: Q2 2026 in Review

RWA Wealth Partners increased its Edwards Lifesciences (EW) stake by 2.3% in Q2 2026, buying an estimated $6.37K and bringing the position to 3,357 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #565.

RWA Wealth Partners first reported a position in EW in Q1 2018 and has held it in 13 quarters since. The position peaked at $531K in Q1 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • RWA Wealth Partners held 3,357 shares of Edwards Lifesciences worth $304K as of Q2 2026.
  • RWA Wealth Partners bought 76 Edwards Lifesciences shares in Q2 2026, an estimated $6.37K.
  • Edwards Lifesciences made up ﹤0.01% of RWA Wealth Partners's portfolio in Q2 2026, its #565 holding.
  • RWA Wealth Partners first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 13 quarters since.
  • RWA Wealth Partners's Edwards Lifesciences position peaked at $531K in Q1 2024.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on RWA Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.